Role of lipid control in diabetic nephropathy
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 67 (94) , S60-S62
- https://doi.org/10.1111/j.1523-1755.2005.09415.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in LDL Receptor-Deficient BALB MiceAmerican Journal of Nephrology, 2004
- Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathyKidney International, 2003
- The Role of Lipids in the Development of Diabetic Microvascular ComplicationsAmerican Journal of Cardiovascular Drugs, 2003
- Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patientsAmerican Journal of Kidney Diseases, 2002
- Atherogenic lipoproteins and diabetes mellitusJournal of Diabetes and its Complications, 2002
- Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patientsDiabetologia, 2000
- The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?Kidney International, 1999
- Apolipoprotein B independently predicts progression of very—low-level albuminuria in insulin-dependent diabetes mellitusMetabolism, 1996
- Renal injury of diet-induced hypercholesterolemia in ratsKidney International, 1990
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988